Regulation of the Na+, glucose cotransporter by PIKfyve and the serum and glucocorticoid inducible kinase SGK1

被引:30
|
作者
Shojaiefard, Manzar
Strutz-Seebohm, Nathalie
Tavare, Jeremy M.
Seebohm, Guiscard
Lang, Florian [1 ]
机构
[1] Univ Tubingen, Dept Physiol, Tubingen, Germany
[2] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England
基金
英国医学研究理事会;
关键词
PIP5K3; kidney; intestine; glucocorticoids; epithelia; obesity;
D O I
10.1016/j.bbrc.2007.05.111
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Na+, glucose cotransporter SGLT1 (SLC5A1) accomplishes Na+-dependent concentrative cellular glucose uptake. SGLT1 activity is enhanced by the serum and glucocorticoid inducible kinase SGK1. As shown recently, the stimulating effect of protein kinase B on the glucose carrier GLUT4 involves the mammalian phosphatidylinositol-3-phosphate-5-kinase PIKfyve (PIP5K3). The present experiments thus explored whether PIKfyve is similarly involved in the SGK1-dependent regulation of SLC5A1. In Xenopus oocytes expressing SLC5A1 but not in water injected oocytes glucose induced a current which was significantly enhanced by coexpression of PIKfyve. The effect of PIKfyve on SLC5A1 was blunted by additional coexpression of the inactive mutant of the serum and glucocorticoid inducible kinase K119N SGK1 and mimicked by coexpression of constitutively active (S422D)SGKI. The stimulating effect of PIKfyve was abrogated by replacement of the serine in the SGK consensus sequence by alanine ((S138A)PIKfyve). Moreover, coexpression of (S138A)PIKfyve significantly blunted the effect of SGKI on SLC5A1 activity. The observations disclose that PIKfyve participates in the SGKI -dependent regulation of SLC5A1. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:843 / 847
页数:5
相关论文
共 50 条
  • [1] Transport regulation by the serum- and glucocorticoid-inducible kinase SGK1
    Lang, F
    Vallon, V
    Grahammer, F
    Palmada, M
    Böhmer, C
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 : 213 - 215
  • [2] Regulation of CFTR by serum- and glucocorticoid-inducible kinase (SGK1)
    Stanton, Bruce A.
    Chapline, M. Christine
    Thibodeau, Renee
    Ryder, Pearl
    Frizzell, Raymond A.
    Sato, J. Denry
    FASEB JOURNAL, 2007, 21 (05): : A547 - A547
  • [3] The serum and glucocorticoid inducible kinase SGK1 in the regulation of renal potassium excretion.
    Lang, F
    Palmada, M
    Boehmer, C
    Embark, HM
    Huang, DY
    Wulff, P
    Kuhl, D
    Yuri, C
    Pearce, D
    Vallon, V
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 80A - 80A
  • [4] Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1
    Lang, Florian
    Shumilina, Ekaterina
    FASEB JOURNAL, 2013, 27 (01): : 3 - 12
  • [5] ETHANOL REGULATION OF SERUM GLUCOCORTICOID KINASE 1 SGK1
    Costin, B. N.
    Miles, M. F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 35 (06) : 257A - 257A
  • [6] ETHANOL REGULATION OF SERUM GLUCOCORTICOID KINASE 1 (SGK1)
    Costin, B. N.
    Miles, M. F.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (06) : 186A - 186A
  • [7] (Serum and glucocorticoid-induced kinase) SGK1: A requisite for transepithelial Na+ transport
    Helms, MN
    Fejes-Toth, G
    Naray-Fejes-Toth, A
    FASEB JOURNAL, 2003, 17 (05): : A912 - A912
  • [8] LEFTYA Activates the Epithelial Na+ Channel (ENaC) in Endometrial Cells via Serum and Glucocorticoid Inducible Kinase SGK1
    Salker, Madhuri S.
    Hosseinzadeh, Zohreh
    Alowayed, Nour
    Zeng, Ni
    Umbach, Anja T.
    Webster, Zoe
    Singh, Yogesh
    Brosens, Jan J.
    Lang, Florian
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 39 (04) : 1295 - 1306
  • [9] The physiological impact of the serum and glucocorticoid-inducible kinase SGK1
    Lang, Florian
    Artunc, Ferruh
    Vallon, Volker
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2009, 18 (05): : 439 - 448
  • [10] Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) in NSCLC Therapy
    Guerriero, Ilaria
    Monaco, Gianni
    Coppola, Vincenzo
    Orlacchio, Arturo
    PHARMACEUTICALS, 2020, 13 (11) : 1 - 25